Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Revenue Climbs 8 Percent in Q4 as Profit Surges 16 Percent

NEW YORK (GenomeWeb News) — General Electric today said that fourth-quarter revenue for its Healthcare division rose 8 percent as income swelled 16 percent.
 
GE Healthcare’s receipts for the three months ended Dec. 31, 2006, rose to $4.85 billion from $4.48 billion year over year.
 
GE Healthcare’s earnings for the quarter increased to $1.15 billion from $995 million in the fourth quarter of 2005.
 
GE did not break out its research and development expenses for the Healthcare segment.
 
GE's total revenues for the quarter were $44.6 billion, up from $40.3 billion during the same period last year.
 
Late yesterday afternoon, GE Healthcare said it plans to buy Abbott Technologies’ in vitro and point-of-care divisions for $8.13 billion in cash.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.